Ultragenyx Stock Today
| RARE Stock | USD 43.69 1.32 3.12% |
Performance1 of 100
| Odds Of DistressLess than 9
|
Ultragenyx is trading at 43.69 as of the 23rd of April 2024, a 3.12 percent increase since the beginning of the trading day. The stock's lowest day price was 42.4. Ultragenyx has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Ultragenyx are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 31st of January 2014 | Category Healthcare | Classification Health Care |
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. The company has 82.34 M outstanding shares of which 3.92 M shares are at this time shorted by private and institutional investors with about 5.41 trading days to cover. More on Ultragenyx
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
Ultragenyx Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ultragenyx's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ultragenyx or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Board Member | Emil Kakkis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, Dow Jones Biotechnology, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Ultragenyx report their recommendations after researching Ultragenyx's financial statements, talking to executives and customers, or listening in on Ultragenyx's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Ultragenyx. The Ultragenyx consensus assessment is calculated by taking the average forecast from all of the analysts covering Ultragenyx. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Ultragenyx's financial statements, Ultragenyx is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Ultragenyx is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ultragenyx's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Ultragenyx's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ultragenyx's financial leverage. It provides some insight into what part of Ultragenyx's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ultragenyx (RARE) is traded on NASDAQ Exchange in USA. It is located in 60 Leveroni Court, Novato, CA, United States, 94949 and employs 1,276 people. Ultragenyx is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.49 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ultragenyx's market, we take the total number of its shares issued and multiply it by Ultragenyx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ultragenyx conducts business under Biotechnology sector and is part of Health Care industry. The entity has 82.34 M outstanding shares of which 3.92 M shares are at this time shorted by private and institutional investors with about 5.41 trading days to cover.
Ultragenyx currently holds about 542.8 M in cash with (474.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.75.
Check Ultragenyx Probability Of Bankruptcy
Ownership AllocationUltragenyx maintains a total of 82.34 Million outstanding shares. The majority of Ultragenyx outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Ultragenyx to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Ultragenyx. Please pay attention to any change in the institutional holdings of Ultragenyx as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Ultragenyx Ownership Details
Ultragenyx Stock Price Odds Analysis
What are Ultragenyx's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Ultragenyx jumping above the current price in 90 days from now is about 87.61%. The Ultragenyx probability density function shows the probability of Ultragenyx stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.2322 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ultragenyx will likely underperform. Additionally, ultragenyx has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Ultragenyx to move above the current price in 90 days from now is about 87.61 (This Ultragenyx probability density function shows the probability of Ultragenyx Stock to fall within a particular range of prices over 90 days) .
Ultragenyx Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Ultragenyx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ultragenyx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ultragenyx's value.| Instituion | Recorded On | Shares | |
| Rock Springs Capital Management Lp | 2023-12-31 | 1.8 M | |
| Alliancebernstein L.p. | 2023-12-31 | 1.6 M | |
| Marshall Wace Asset Management Ltd | 2023-12-31 | 1.5 M | |
| Baker Bros Advisors Lp | 2023-12-31 | 1.5 M | |
| Geode Capital Management, Llc | 2023-12-31 | 1.3 M | |
| Deutsche Bank Ag | 2023-12-31 | 1.2 M | |
| First Trust Advisors L.p. | 2023-12-31 | 1.2 M | |
| Adage Capital Partners Gp Llc | 2023-12-31 | 1 M | |
| Pictet Asset Manangement Sa | 2023-12-31 | 1 M | |
| Vanguard Group Inc | 2023-12-31 | 8.7 M | |
| Rtw Investments, Llc | 2023-12-31 | 6.9 M |
Ultragenyx Historical Income Statement
Ultragenyx Income Statement is one of the three primary financial statements used for reporting Ultragenyx's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Ultragenyx revenue and expense. Ultragenyx Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Ultragenyx's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 325.3 M, whereas EBIT is projected to grow to (515.7 M). View More FundamentalsUltragenyx Stock Against Markets
Picking the right benchmark for Ultragenyx stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Ultragenyx stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Ultragenyx is critical whether you are bullish or bearish towards Ultragenyx at a given time. Please also check how Ultragenyx's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ultragenyx without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Investment Finder Now
AI Investment FinderUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Ultragenyx Corporate Directors
Ultragenyx corporate directors refer to members of an Ultragenyx board of directors. The board of directors generally takes responsibility for the Ultragenyx's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Ultragenyx's board members must vote for the resolution. The Ultragenyx board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Daniel Welch | Director | Profile | |
| Lars Ekman | Independent Director | Profile | |
| Deborah Dunsire | Independent Director | Profile | |
| Michael Narachi | Director | Profile |
How to buy Ultragenyx Stock?
Before investing in Ultragenyx, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Ultragenyx. To buy Ultragenyx stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Ultragenyx. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Ultragenyx stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Ultragenyx stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Ultragenyx stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Ultragenyx, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Ultragenyx Stock please use our How to Invest in Ultragenyx guide.
Already Invested in Ultragenyx?
The danger of trading Ultragenyx is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ultragenyx is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ultragenyx. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ultragenyx is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Ultragenyx Stock analysis
When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Ultragenyx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.25) | Revenue Per Share 5.905 | Quarterly Revenue Growth 0.233 | Return On Assets (0.23) | Return On Equity (1.93) |
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.